New book by Larry Connors Click here Improve your trading - See how
TeleTech is one of just five local premier sponsors. The premier sponsorship is a direct result of TeleTech employees' tremendous passion for the cause. In addition to the corporate sponsorship, TeleTech employees have raised more than $100,000 for the Denver Metropolitan Affiliate of Susan G. Komen for the Cure in the past four years, including race registration fees.
"We are very proud of our employees' remarkable efforts to support such an important cause," said Kenneth Tuchman, TeleTech chairman and chief executive officer. "In four years, we have more than doubled the number of TeleTech team registrants and significantly increased the amount of donations."
New this year, Jennifer Alverson and Kelsey Pachak, two TeleTech employees, along with TeleTech's chief financial officer John Troka, will cheer on thousands of runners and walkers as the official starters of the 2009 Komen Denver Race for the Cure.
Alverson and Pachak spearheaded TeleTech's fundraising efforts for the Denver race. "The first year we had three weeks to get the word out about the race. We managed to get more than 100 people on our team and raised nearly $20,000. After that, we certainly started getting attention," said Ms. Alverson, whose mother was diagnosed with breast cancer five years ago, and is a healthy survivor today who supports Komen's efforts.
The TeleTech Community Foundation has developed creative ways to raise money for Susan G. Komen for the Cure beyond encouraging employees to register for the Komen Denver Race for the Cure. During the company's annual 'Pink Week,' TeleTech employees raise money through:
-- Selling casual days to employees
-- Selling pink food in the company cafeteria
-- Selling items at a silent auction
-- Accepting donations in the form of paid time off, which is converted
into monetary donations to Komen
ABOUT TELETECH
TeleTech is one of the largest and most geographically diverse global providers of business process outsourcing solutions. TeleTech and its subsidiaries have a 27-year history of designing, implementing, and managing critical business processes for Global 1000 companies to help them improve their customers' experience, expand their strategic capabilities, and increase their operating efficiencies. By delivering a high-quality customer experience through the effective integration of customer-facing front-office processes with internal back-office processes, we enable our clients to better serve, grow, and retain their customer base. We use Six Sigma-based quality methods continually to design, implement, and enhance the business processes we deliver to our clients and we also apply this methodology to our own internal operations. TeleTech and its subsidiaries have developed deep domain expertise and support more than 250 business process outsourcing programs serving approximately 100 global clients in the automotive, communications and media, financial services, government, healthcare, retail, technology and travel and leisure industries. Our integrated global solutions are provided by approximately 48,000 employees utilizing 37,000 workstations across 77 delivery centers in 17 countries. For additional information, visit www.teletech.com.
ABOUT THE DENVER METROPOLITAN AFFILIATE OF SUSAN G. KOMEN FOR THE CURE:
The Denver Affiliate of Susan G. Komen for the Cure -- along with those who generously support us with their talent, time and resources -- is working to better the lives of those facing breast cancer in the community. Since 1993, through events like the Komen Denver Race for the Cure and A Pink Tie Affair(TM), we have invested $23 million in local breast health and breast cancer awareness projects in 12 counties. Up to 75 percent of net proceeds generated by the Komen Denver Affiliate stay in the 12-county service area. This year, the Affiliate is funding 35 grants in its 12-county service area, totaling $2.83 million and invested nearly $1 million into breast cancer research. The Affiliate has also contributed nearly $9 million to scientific research through Susan G. Komen for the Cure(R) Grants Program over the past 15 years. For more information, visit www.komendenver.org or call 303-744-2088.
ABOUT SUSAN G. KOMEN FOR THE CURE:
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, the promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure(R), we have invested nearly $1 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit www.komen.org or call 1-877 GO KOMEN.
Investor Contact: Karen Breen 303-397-8592 Media Contact: Maria Miller SSA PR 303-707-1776
SOURCE: TeleTech Holdings
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.